We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Reveals FDA's Part 11 Enforcement Stance
Warning Letter Reveals FDA's Part 11 Enforcement Stance
June 6, 2005
A recent warning letter citing 21 CFR Part 11 validation and control requirements sends a clear signal that the FDA intends to enforce the electronic records and signatures rule even as the agency moves toward revising it, industry experts say.